Adjuvant Versus Neoadjuvant Androgen Deprivation With Radiotherapy for Prostate Cancer: Does Sequencing Matter?

Pilepich, 2005, Androgen suppression adjuvant to definitive radiotherapy in prostate carcinoma—long-term results of phase III RTOG 85-31, Int J Radiat Oncol Biol Phys, 61, 1285, 10.1016/j.ijrobp.2004.08.047

Roach, 2008, Short-term neoadjuvant androgen deprivation therapy and external-beam radiotherapy for locally advanced prostate cancer: long-term results of RTOG 8610, J Clin Oncol, 26, 585, 10.1200/JCO.2007.13.9881

Bolla, 2010, External irradiation with or without long-term androgen suppression for prostate cancer with high metastatic risk: 10-year results of an EORTC randomised study, Lancet Oncol, 11, 1066, 10.1016/S1470-2045(10)70223-0

Horwitz, 2008, Ten-year follow-up of Radiation Therapy Oncology Group protocol 92-02: a phase III trial of the duration of elective androgen deprivation in locally advanced prostate cancer, J Clin Oncol, 26, 2497, 10.1200/JCO.2007.14.9021

Bolla, 2009, Duration of androgen suppression in the treatment of prostate cancer, N Engl J Med, 360, 2516, 10.1056/NEJMoa0810095

Lawton, 2007, An update of the phase III trial comparing whole pelvic to prostate only radiotherapy and neoadjuvant to adjuvant total androgen suppression: updated analysis of RTOG 94-13, with emphasis on unexpected hormone/radiation interactions, Int J Radiat Oncol Biol Phys, 69, 646, 10.1016/j.ijrobp.2007.04.003

Mohler, 2012, Prostate cancer, version 3.2012, featured updates to the NCCN guidelines, J Natl Compr Canc Netw, 10, 1081, 10.6004/jnccn.2012.0114

Roach, 2006, Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: recommendations of the RTOG-ASTRO Phoenix Consensus Conference, Int J Radiat Oncol Biol Phys, 65, 965, 10.1016/j.ijrobp.2006.04.029

Kuban, 2008, Long-term results of the MD Anderson randomized dose-escalation trial for prostate cancer, Int J Radiat Oncol Biol Phys, 70, 67, 10.1016/j.ijrobp.2007.06.054

Zietman, 2010, Randomized trial comparing conventional-dose with high-dose conformal radiation therapy in early-stage adenocarcinoma of the prostate: long-term results from Proton Radiation Oncology Group/American College of Radiology 95-09, J Clin Oncol, 28, 1106, 10.1200/JCO.2009.25.8475

Peeters, 2006, Dose-response in radiotherapy for localized prostate cancer: results of the dutch multicenter randomized phase III trial comparing 68 Gy of radiotherapy with 78 Gy, J Clin Oncol, 24, 1990, 10.1200/JCO.2005.05.2530

Dubray, 2011, Does short-term androgen depletion add to high-dose radiotherapy (80 Gy) in localized intermediate-risk prostate cancer? Intermediary analysis of GETUG 14 randomized trial (EU-20503/NCT00104741), J Clin Oncol, 29, abstr 4521, 10.1200/jco.2011.29.15_suppl.4521

Valicenti, 2011, Does hormone therapy reduce disease recurrence in prostate cancer patients receiving dose-escalated radiation therapy? An analysis of Radiation Therapy Oncology Group 94-06, Int J Radiat Oncol Biol Phys, 79, 1323, 10.1016/j.ijrobp.2010.01.009

Zelefsky, 2008, Long-term results of conformal radiotherapy for prostate cancer: impact of dose escalation on biochemical tumor control and distant metastases-free survival outcomes, Int J Radiat Oncol Biol Phys, 71, 1028, 10.1016/j.ijrobp.2007.11.066

Zelefsky, 2011, Dose escalation for prostate cancer radiotherapy: predictors of long-term biochemical tumor control and distant metastases-free survival outcomes, Eur Urol, 60, 1133, 10.1016/j.eururo.2011.08.029

Castle, 2013, Is androgen deprivation therapy necessary in all intermediate-risk prostate cancer patients treated in the dose escalation era?, Int J Radiat Oncol Biol Phys, 85, 693, 10.1016/j.ijrobp.2012.06.030

Zietman, 1997, Androgen deprivation and radiation therapy: sequencing studies using the shionogi in vivo tumor system, Int J Radiat Oncol Biol Phys, 38, 1067, 10.1016/S0360-3016(97)00309-X

Kaminski, 2003, Effect of sequencing of androgen deprivation and radiotherapy on prostate cancer growth, Int J Radiat Oncol Biol Phys, 57, 24, 10.1016/S0360-3016(03)00539-X

Pinthus, 2007, Androgen induces adaptation to oxidative stress in prostate cancer: implications for treatment with radiation therapy, Neoplasia, 9, 68, 10.1593/neo.06739

Buttyan, 2000, The effects of androgen deprivation on the prostate gland: cell death mediated by vascular regression, Curr Opin Urol, 10, 415, 10.1097/00042307-200009000-00009